EMN vs GGB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Eastman Chemical Company presents a concerning profile characterized by a stable but mediocre Piotroski F-Score of 4/9 and a significant disconnect between its current price ($70.42) and its growth-based intrinsic value ($28.7). While the stock trades near its Graham Number ($69.44), suggesting defensive fair value, this is offset by a severe collapse in earnings growth (-67.50%) and negative revenue growth (-12.10%). The high dividend payout ratio of 81.22% combined with a bearish technical trend (0/100) suggests the company is struggling to maintain its valuation amidst deteriorating fundamentals.
GGB presents a dichotomy between a strong balance sheet and poor operational performance. The Piotroski F-Score of 4/9 indicates stable but mediocre financial health, while the current price of $4.32 sits slightly above the Graham Number ($4.14) and significantly above the growth-based intrinsic value ($0.98). While the company maintains low leverage and high liquidity, consistent earnings misses (0/4 in the last year) and thin profit margins suggest fundamental weakness despite recent price momentum.
Compare Another Pair
Related Comparisons
EMN vs GGB: Head-to-Head Comparison
This page compares Eastman Chemical Company (EMN) and Gerdau S.A. (GGB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.